Dr Lorraine Chantrill gets Gutsy for GI Cancer

Support Dr Lorraine Chantrill with her Larapinta Gutsy Challenge Trek. Dr. Lorraine Chantrill, AGITG Board Member and medical oncologist with a focus on pancreatic cancer research, will be heading off on her 80km trek of the Larapinta Trail on Sunday 6th August. Her motivation for setting herself this challenge is personal. As … Read More

July 27, 2017

AGITG Trial News

The AGITG currently has eight  studies open to recruitment and ten  studies in follow up. The  table below details  the trials that  are currently  accruing patients. Recruited Target ACTICCA-1- Gallbladder carcinoma 2 50 ALT-GIST- GI Stromal Tumour 18 60 ASCOLT — Colorectal cancer 227 300 CONTROL NETs — NeuroEndocrine Tumour … Read More

July 5, 2017

Key ASCO Presentations on GI Cancer

A number of AGITG members attended this year’s American Society of Clinical Oncology (ASCO) meeting in Chicago (2-6 June). Following ASCO NEJM Journal Watch Oncology and Hematology have published an article which provides reviews by Associate Editor David H. Ilson, MD, PhD, of key presentations on new Gastro-Intestinal cancer treatments. … Read More

June 21, 2017

Advanced GIST Trial results published in JCO

The Advanced GIST trial results were recently published in May in the Journal Of Clinical Oncology. Title: Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials … Read More

June 6, 2017

AGITG Clinical Trial research at ASCO

The final results of the AGITG ICECREAM  trial were presented at this year’s ASCO meeting in Chicago on 3 June, 2017. Many AGITG members and international colleagues participated in this important study, one of the first prospective trials to limit accrual to pre-defined molecular subsets of colorectal cancer. Professor Jeremy Shapiro (pictured … Read More

June 5, 2017

Clinical Trials Funding Announced

The AGITG welcomes the recent announcement by Minister Hunt, Federal Minister of Health, of a $33 million funding package to lift clinical trials and registries capacity and better support clinician researchers. This is a critical first step towards ensuring health and medical research is focused on maximising public benefit. As … Read More

May 24, 2017

Senate Inquiry into Funding for Research

On 29 November 2016 the Senate established the Select Committee into ‘Funding for Research into Cancers with Low Survival Rates’ to inquire and report on the impact of health research funding models and the availability of funding for research into cancers with low survival rates. The committee is to inquire … Read More

May 19, 2017

AGITG at ASCO 2017

AGITG Abstracts to be presented at ASCO include ICECREAM and INTEGRATE II. They are now available online. 1. Results of the Quad wild type arm of the AGITG ICECREAM study: A randomised phase II study of cetuximab alone or in combination with irinotecan in patients with refractory metastatic colorectal cancer with … Read More

May 18, 2017

Welcoming our new CAP members!

On Thursday 11 May our Consumer Advisory Panel (CAP) met in Sydney – welcoming five new members to the Panel and farewelling two longstanding members – Dan Kent and Joe Levin. Established in 2008, the CAP comprises of GI cancer survivors, patients and carers. All CAP members volunteer their time … Read More

May 18, 2017

Deciding on a future in the field of Upper GI Cancer

Supported by an education sponsorship by Shire, 39 early career cancer clinicians – including consultants in Medical, Radiation and Surgical Oncology – gathered earlier in May to learn from the experts at the AGITG Preceptorship in Upper GI Cancer. This two day intensive learning course involves a complete review of … Read More

May 18, 2017